All outcomes regarding the efficacy of GLP-1 RAs in MASLD were summarized into five categories: liver characteristics, liver enzyme levels, anthropometric measurements, metabolic markers, and inflammatory markers
Glucagon-like peptide-1 (GLP-1) is an incretin hormone derived from the transcription product of the proglucagon gene, primarily secreted by intestinal L-cells in response to nutrient intake [1]
This may apply to medications such as: ACE inhibitors ARBs Beta blockers Calcium channel blockers Diuretics Some patients eventually require lower doses of blood pressure medication after significant weight loss
eventuali disturbi cardiovascolari
Monitoring helps ensure the medications are working correctly and that no adverse interactions occur
Peptides trigger the production of IGF-1, VEGF, FGF, and KGF, all of which promote stem cell activation, dermal papilla proliferation and follicle regeneration